SC 13G/A: MAINZ BIOMED N.V.

AI Summary

SC 13G/A filing by MAINZ BIOMED N.V..

Risk Assessment

Risk Level: low

FAQ

Filing Documents

• d29518dsc13ga.htm (SC 13G/A) — 45KB
• 0001193125-24-233847.txt ( ) — 47KB

From the Filing

SC 13G/A 1 d29518dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 2)* Under the Securities Exchange Act of 1934 MAINZ BIOMED N.V. (Name of Issuer) Ordinary Shares, nominal value of 0.01 per share (Titles of Class of Securities) N5436L101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ). CUSIP No. N5436L101 SCHEDULE 13G Page 2 of 6 1 NAME OF REPORTING PERSON OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON KfW 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Germany NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 928.127 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 928.127 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 928.127 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.4 (1) 12 TYPE OF REPORTING PERSON OO (1) Calculated based on 21,165,482 ordinary shares of Mainz Biomed N.V. outstanding as of December 31, 2023, as disclosed in its annual report filed with the Securities and Exchange Commission on April 9, 2024. CUSIP No. N5436L101 SCHEDULE 13G Page 3 of 6 Item1(a). Name of Issuer: Mainz Biomed N.V. Item1(b). Address of Issuers Principal Executive Offices: Robert Koch Strasse 50, 55129 Mainz, Germany Item2(a). Name of Person Filing: Kreditanstalt für Wiederaufbau Item2(b). Address of Principal Business Office or, if none, Residence: Palmengartenstrasse 5-9, 60325 Frankfurt am Main, Germany Item2(c). Citizenship: Germany Item2(d). Titles of Classes of Securities: Ordinary Shares, nominal value of 0.01 per share Item2(e). CUSIP Number: N5436L101 Item3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a(n): (a) Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o). (b) Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c). CUSIP No. N5436L101 SCHEDULE 13G Page 4 of 6 (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c). (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) Investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). (f) Employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F). (g) Parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G). (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) Non-U.S. institution, in accordance with 240.13d-1(b)(1)(ii)(J). (k) Group in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240. 13d-1(b)(1)(ii)(J), please specify the type of institution: Item4. (a) Amount beneficially owned: See response to Item 9 on the cover page. (b) Percent of class: See response to Item 11 on the cover page. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See response to Item 5 on the cover page. (ii) Shared power to vote or to direct the vote: See response to Item 6 on the cover page. CUSIP No. N5436L101 SCHEDULE 13G Page 5 of 6 (iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on the cover page. (iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on the cover page. Item5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. Item6. Not Applicable. Item7. Identification and Classificatio

View Full Filing

View this SC 13G/A filing on SEC EDGAR